Duangnapa Kiriwan

Cell‐penetrable nanobodies (transbodies) that inhibit the tyrosine kinase activity of EGFR leading to the impediment of human lung adenocarcinoma cell motility and survival

Lueacha Tabtimmai, Praphasri Suphakun, Pimonwan Srisook et al. · Journal of Cellular Biochemistry · 2019 · 34 citations

Medicine, Oncology, Pharmacology +14

Chamuangone from <i>Garcinia cowa</i> leaves inhibits cell proliferation and migration and induces cell apoptosis in human cervical cancer <i>in vitro</i>

Pirunrat Sae-Lim, Supaphorn Seetaha, Lueacha Tabtimmai et al. · Journal of Pharmacy and Pharmacology · 2019 · 18 citations

Medicine, Oncology, Pharmacology +16

Generation of a nanobody against HER2 tyrosine kinase using phage display library screening for HER2-positive breast cancer therapy development

Thomanai Lamtha, Lueacha Tabtimmai, Kunan Bangphoomi et al. · Protein Engineering Design and Selection · 2021 · 18 citations · Full text

Pharmacy, Cancer Biology, Oncology +17

Molecular dynamics, MM/PBSA and in vitro validation of a novel quinazoline-based EGFR tyrosine kinase inhibitor identified using structure-based in silico screening

Narittira Ornnork, Duangnapa Kiriwan, Kriengsak Lirdprapamongkol et al. · Journal of Molecular Graphics and Modelling · 2020 · 17 citations

Pharmacy, Medicinal Chemistry, Oncology +15

Development of a biosensor from aptamers for detection of the porcine reproductive and respiratory syndrome virus

Chakpetch Kuitio, Natchaya Rasri, Duangnapa Kiriwan et al. · Journal of Veterinary Science · 2020 · 13 citations · Full text

Engineering, Bioengineering, Infectious Diseases +17